e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Update on monitoring airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lipid peroxidation products-diagnostic utility in differentation of pleural effusions
J. Lalic, I. Lalic, I. Djordjevic, M. Ljubenovic (Nis, Republic Of Serbia)
Source:
Annual Congress 2011 - Update on monitoring airway diseases
Session:
Update on monitoring airway diseases
Session type:
Thematic Poster Session
Number:
4013
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Lalic, I. Lalic, I. Djordjevic, M. Ljubenovic (Nis, Republic Of Serbia). Lipid peroxidation products-diagnostic utility in differentation of pleural effusions. Eur Respir J 2011; 38: Suppl. 55, 4013
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Diagnostic significance of lipid peroxidation products in differentiation of pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 308s
Year: 2005
Lipid peroxidation products-diagnostic utility in separation of exudates from transudates
Source: Eur Respir J 2002; 20: Suppl. 38, 442s
Year: 2002
Is pleural cholesterol useful for differentiation between exudates and transudates?
Source: Eur Respir J 2005; 26: Suppl. 49, 447s
Year: 2005
Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005
Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
Glutathione peroxidase levels in transudative and exudative pleural effusions
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Novel Synthetic lignan reduces asbestos-induced damage in human pleural mesothelial cells-Potential clinical usefulness in inhibiting pleural malignant mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Usfulness of cholesterol in difering malignant and nonmalignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006
Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Enzyme diagnosis of pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 51s
Year: 2006
Measurement of pleural fluid lactate dehydrogenase and adenosine deaminase for distinguishing malignant pleural effusions and other exudative pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Diagnostic usefulness of tumour markers in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Diagnostic yield of sl-selectin in differentiation of transudates from exudates in pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept